Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
David Brennan to retire as AstraZeneca’s Chief Executive Officer
-
AstraZeneca and The Medicines Company announce global collaboration in acute ischaemic heart disease
-
AstraZeneca to acquire Ardea Biosciences for $1 billion (net of existing cash) including lead product lesinurad in Phase III development for gout
-
FORXIGA (dapagliflozin) receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes
-
AstraZeneca and Amgen announce collaboration to jointly develop and commercialise clinical-stage inflammation portfolio
-
US District Court finds SEROQUEL XR® formulation patent valid and infringed
-
US court denies preliminary injunction application against the FDA and dismisses AstraZeneca’s lawsuit without prejudice
-
UK court finds SEROQUEL XR® formulation patent invalid
-
Remaining TC-5214 Phase III efficacy studies do not meet endpoint, regulatory filing will not be pursued
-
AstraZeneca files lawsuit against the FDA for decision regarding quetiapine product labelling and exclusivity
Latest articles and press releases
All of our latest press releases and articles are available to explore
